< Back to latest news & events

Event

Patenting computer-implemented healthcare inventions in AI and Machine Learning

April 2020

Event date: 23rd April 2020

WIPR Insights and HGF Limited present:  ‘Patenting computer-implemented healthcare inventions in AI and Machine Learning’. HGF Patent Director Dr Andrew McGettrick will be presenting a live webinar on 23rd April at 3pm.

The European Patent Office (EPO) has recognised the importance of artificial intelligence (AI) and machine learning by updating the EPO Guidelines for Examination to focus on the patentability of innovations having an AI aspect. The EPO held a conference in 2018 directed to patenting AI, testament to the impact AI is having in all areas of technology.

It is a common misconception that computer software cannot be patented. Although not all software is patentable, software in the medical technology field is often patentable. Navigating exclusions to patentability can be a challenge with AI inventions because they can be viewed as a form of mathematical method, which are on the list of non-inventions defined by the European Patent Convention.

Although routine implementation of AI or machine learning to solve a problem foreseeably solvable by AI is unlikely to be sufficient to obtain patent protection, it is eminently possible to obtain patent protection for AI inventions.

This webinar will explore by example how to approach the patenting of AI inventions in the medical field and how to navigate the exclusions from patentability, including some types of computer software, pure mathematical methods and methods of diagnosis.

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article